, Volume 19, Issue 2, pp 247–252 | Cite as

Complex ventral hernia repair with a human acellular dermal matrix

  • J. S. Roth
  • C. Brathwaite
  • K. Hacker
  • K. Fisher
  • J. King
Open Access
Original Article



The ideal approach to complex ventral hernia repair is frequently debated. Differences in processing techniques among biologic materials may impact hernia repair outcomes. This study evaluates the outcomes of hernia repair with a terminally sterilized human acellular dermal matrix (TS-HADM) (AlloMax® Surgical Graft, by C. R. Bard/Davol, Inc., Warwick, RI, USA) treated with low-dose gamma irradiation.


A single-arm multi-center retrospective observational study of patients undergoing hernia repair with TS-HADM was performed. Data analyses were exploratory only; no formal hypothesis testing was pre-specified.


Seventy-eight patients (43F, 35M) underwent incisional hernia repair with a TS-HADM. Mean follow-up was 20.5 months. Preoperative characteristics include age of 56.6 ± 11.1 years, BMI 36.7 ± 9.9 kg/m2, and mean hernia defect size 187 cm2. Sixty-five patients underwent component separation technique (CST) with a reinforcing graft. Overall, 21.8 % developed recurrences. Recurrences occurred in 15 % of patients repaired with CST. Major wound complications occurred in 31 % of patients overall. Based upon CDC surgical wound classification, major wound complications were seen in 26, 40, 56, and 50 % of Class 1, 2, 3, and 4 wounds, respectively. No grafts required removal.


Hernia recurrences are not uncommon following complex abdominal wall reconstruction. Improved outcomes are seen when a TS-HADM is utilized as reinforcement to primary fascial closure.


Component separation Human acellular dermal matrix Biologic mesh Ventral hernia 


Abdominal operations are among some of the most commonly performed surgical procedures with an estimate of 4–5 million laparotomies performed annually in the United States [1]. Although there is considerable interest in hernia prophylaxis, the incidence of incisional hernia formation following laparotomy remains significant with a reported incidence as high as 20 % [2, 3]. The majority of incisional hernias may be successfully repaired utilizing synthetic mesh materials with a reasonable recurrence rate [1, 4, 5]. However, a proportion of those patients undergoing incisional hernia repair will develop recurrences and complications [4, 5]. Prosthetic mesh-related complications including mesh infections, extrusions, and enterocutaneous fistulas, although rare, are a significant burden to the health care system [6]. The management of these complications and complex recurrent incisional hernias has become an increasing challenge for surgeons and patients alike owing to the increase in both morbidity and recurrences among this group.

The use of human acellular dermal matrices (HADMs) for the repair of complex incisional hernias has been reported extensively [7, 8, 9, 10, 11, 12, 13]. Initial reports demonstrated early successes; however, subsequent reports revealed hernia recurrence rates approaching 100 % when these materials were utilized to bridge hernia defects [7]. HADMs are most commonly utilized during hernia procedures in which there is contamination, infection, or an increased risk for postoperative wound complications [14]. HADMs appear to be safe when placed into high-risk and contaminated wounds [10, 11, 13]. In general, the presence of contamination or infection has been considered a contraindication to the utilization of synthetic mesh materials. Accordingly, HADMs provide surgeons with an alternative hernia repair strategy when a synthetic mesh is not appropriate and alternative strategies such as flaps or tissue transfers would have otherwise been required. When utilized as reinforcement to a component separation hernia repair, HADMs have been shown to reduce recurrences [15], although this remains an area of controversy [16]. Although all HADMs originate as donated human tissue, processing techniques differ which may impact material properties, host responses, and ultimately surgical outcomes [17, 18, 19].

In this study, we evaluate the outcomes of patients undergoing complex ventral hernia repair utilizing a terminally sterilized human acellular dermal matrix, AlloMax™ Surgical Graft (TS-HADM). Sterilization of the graft occurs by means of low-dose gamma irradiation. Prior studies have demonstrated the efficacy of TS-HADM in the repair of paraesophageal hernias [20], but outcomes following abdominal wall hernia repair have not been reported.


After obtaining Institutional Review Board approval, a single-arm, multi-center, observational study of patients who had previously undergone hernia repair with a TS-HADM was performed. Patients who had undergone ventral hernia repair with a TS-HADM a minimum of 9 months prior to study enrollment were included. Consented patients underwent review of medical records for risk factors for hernia recurrence, procedural details, complications, and recurrences. Patients without evidence of hernia recurrence following record review were prospectively evaluated for hernia recurrence by means of a physical examination. Patients with documented evidence of hernia recurrence by imaging or prior physical examination were not required to complete a further physical examination.

Patients were enrolled at four medical centers including: Barnes Jewish St. Peters Hospital, St Peters, MO; St. Francis Hospital, Tulsa, OK; Winthrop University Hospital, Mineola, NY; and University of Kentucky, Lexington, KY. Only those patients, at least 18 years of age, who had undergone a ventral hernia repair with the TS-HADM were included in the study group. Medical records were reviewed for risk factors for hernia recurrence including cancer, infection, obesity, history of prior hernia, immunosuppression, smoking, malnutrition, diabetes mellitus, anemia, liver disease, pulmonary disease, and prior abdominal surgery.

Hernia repairs were stratified by the Centers for Disease Control and Prevention (CDC) surgical wound classification which includes Class 1 (clean), Class 2 (clean-contaminated), Class 3 (contaminated) and Class 4 (dirty-infected). Operative details were obtained including operative date and time, procedure type (use of component separation, graft location, buttressed or bridging repair, recurrent or primary), suture type, defect size, graft size, number of grafts utilized, degree of fascial closure/bridging, skin closure, hernia wound classification, antibiotic use, and serum albumin level. Patients were considered to have an onlay repair if any graft was placed in a location ventral to the fascial closure, whereas non-onlay repairs include retro-rectus, preperitoneal, and intraperitoneal grafts.

Hernia recurrence was defined as any patient in whom the medical record documented a recurrent bulge by means of physical examination or radiographic studies or alternatively patients in whom a recurrent hernia was detected upon physical examination. Subsets of patient complications were defined as minor, major skin and soft tissue complications, seroma or hematoma. Minor complications were defined as cellulitis, epidermolysis, lymphedema, ecchymosis or erythema. Major skin and soft tissue complications include superficial wound infection, abdominal abscess, non-healing wounds, surgical site infections, postoperative wound infections, abdominal wall necrosis, and infected hematomas. Seromas and hematomas include only uninfected collections of fluid or blood, respectively.

Statistical analysis methods

Data from all investigational sites were pooled and summarized. Numerical data such as age, BMI, hernia defect size were reported as Mean ± SD; while categorical data such as wound complication rate, recurrence rate were reported as count and percentages. There was no pre-planned formal hypothesis for testing. For exploratory purpose, univariate Chi-square test was used to compare the rate of wound complications and recurrence rates among group of subjects classified based on preoperative Center for Disease Control hernia wound classification.


Seventy-eight patients were identified who underwent ventral or incisional hernia repair with a TS-HADM. Repairs were performed between 2007 and 2010. There were 43 female and 35 male patients with a mean age of 56.6 ± 11.1 years (range 33–85), and a mean body mass index of 36.7 ± 9.9 kg/m2 (range 22–89). Mean follow-up was 622 days (range 274–1,529 days). Forty-seven patients (64 %) underwent repair for a recurrent hernia. Among recurrent hernia repairs, the mean number of prior repairs was 2.1 ± 1.5 procedures. Preoperative patient co-morbidities included smoking, diabetes mellitus, anemia, cancer, pulmonary disease, hepatic disease, immunosuppression, malnutrition, obesity, and hypoalbuminemia (Table 1). Patients’ preoperative Center for Disease Control (CDC) wound classification was Class 1 (n = 53, 72 %), Class 2 (n = 10, 14 %), Class 3 (n = 9, 12 %), and Class 4 (n = 2, 3 %).
Table 1

Preoperative characteristics

Comorbid conditions

n (%)

Current smoker

14 (17.9)

Prior abdominal infection

38 (48.7)

Prior mesh infection

17 (21.8)


13 (16.7)


17 (21.8)

Diabetes mellitus

26 (33.3)


9 (11.5)

Hepatic disease

4 (5.1)

Pulmonary disease

18 (23.1)


2 (2.6)


63 (80.8)

Recurrent hernia

50 (64.1)

Preoperative albumin <3.4 mg/dl

3 (3.8)

Seventy-one patients underwent hernia repair with primary defect closure and placement of a TS-HADM graft as a reinforcement, of which 65 patients underwent a component separation procedure. Five patients underwent placement of a graft as a bridge (Table 2). In two patients, it was unclear whether the graft was used as a reinforcement or bridge. Surgical grafts were placed as either an onlay, retromuscular or preperitoneal underlay, intraperitoneal underlay or utilized a combination of underlay and overlay techniques. The mean hernia defect size measured intraoperatively was 178 ± 156 cm2, whereas the mean graft size was 348 ± 296 cm2. Hernia recurrences were seen in 17 patients (21.8 %) and were detected by either physical examination (n = 9) and/or radiologic imaging (n = 9). Recurrent hernias occurred less frequently among those patients who underwent hernia repair with a reinforcing mesh than other techniques. Fewer recurrences were also seen in those with underlay TS-HADM placement (retromuscular, preperitoneal or intraperitoneal) versus onlay placement, although not significant (6/33 vs. 11/45, p = 0.508).
Table 2

Operative details and hernia recurrence rates

Graft position

n (%)

Recurrence rate n (%)


45 (58)

11 (24)


33 (42)

6 (18)a

Hernia repair technique

 Component separation with reinforcing graft

65 (83)

10 (15)

 Defect closure with Reinforcing graft

6 (8)

2 (33)

 Bridging graft

5 (7)

4 (80)b

aOnlay/not onlay p = 0.508 (univariate)

bBridging/reinforcing p = 0.0005 (univariate)

Wound complications were seen in patients who underwent repair with TS-HADM utilizing both onlay and underlay techniques. The incidence of postoperative seroma was 40 % in the overlay group, while 21 % of underlay repairs (including bilayer grafts) developed postoperative seromas (Table 3). There was a trend toward increased postoperative major wound complications associated with increasing CDC surgical wound classification, and no significant impact of CDC wound class upon recurrences (Table 4).
Table 3

Wound complications by graft location


Onlay graft (n = 45) (%)

Non-onlay graft (n = 33) (%)

Minor wound complications

11 (24.4)

5 (16)

Major wound complications

16 (35.5)

8 (24)


18 (40)

5 (21)


1 (2.2)

3 (9)

Table 4

Major wound complications and hernia recurrences by CDC wound classification

CDC wound class

Major wound complications n (%)*

Recurrence n (%)**

Class 1/clean

14 (26)

13 (25)

Class 2/clean-contaminated

4 (40)

2 (20)

Class 3/contaminated

5 (56)

0 (0)

Class 4/dirty or infected

1 (50)

0 (0)

*p = 0.068 (univariate)

** p = 0.082 (univariate)


Hernia repair remains as one of the most commonly performed operations in the United States with an increasing number of incisional hernia repairs annually [21]. Despite best practices, hernia recurrences remain a significant challenge. The use of prosthetic materials has decreased the incidence of hernia recurrence [1, 4] although there are clearly unique complications related to the utilization of synthetic materials for hernia repair [6]. Many techniques for hernia repair have evolved in an attempt to both minimize hernia recurrences and reduce perioperative complications. This study evaluates the results of hernia repairs performed at four institutions utilizing a TS-HADM. Although the total number of hernia repairs at these four institutions was not evaluated, the number of patients included in this study represents a minority of all ventral hernias that were performed at these institutions and the authors believe that synthetic mesh should be utilized for the overwhelming majority of hernia repairs.

The component separation technique for hernia repair was described as a unique technique for the management of complex abdominal wall hernias in situations in which prosthetic material was felt to be not appropriate or feasible [22]. Although the initial description of component separation did not involve the placement of a reinforcing prosthetic material, the practice of reinforcing the midline closure following component separation, in an attempt to further reduce the risk of recurrence, has been reported [15, 16, 23]. The ideal prosthetic material for reinforcement of the abdominal wall is an area of tremendous controversy. Espinosa-de-Los-Monteros described a 13 % reduction in the risk of hernia recurrences when component separation hernia repairs were reinforced with a HADM [15]. A more recent report by Ko et al., however, demonstrated a reduced rate of hernia recurrence among those patients who underwent reinforcement with a polypropylene mesh compared to a HADM [16, 24]. In our series, the recurrence rate for patients who underwent component separation with TS-HADM reinforcement was 15 % with a mean follow-up of 20.5 months. This recurrence rate is similar to other reports of reinforced component separation repairs with either synthetic mesh or biologic grafts [16, 23, 24].

In this study, the majority of patients were considered to be at increased risk of wound complications and recurrence due to their pre-existing comorbid conditions. Nearly one-third of the study population experienced a major wound complication in this study. Despite this significant incidence of wound complications, there were no patients in this study who required graft removal. In a study of 545 component separation operations reported by Sailes et al. [23], there was an increased incidence of mesh infections seen with synthetic meshes compared with biologic grafts. Although synthetic mesh infections may be treated non-operatively, postoperative synthetic mesh infections are a source of additional morbidity and may necessitate mesh removal [25]. On the contrary, placement of a biologic graft at the time of a component separation is unlikely to result in the need for graft explant even in the presence of a postoperative infectious complication [8]. The ideal prosthetic for reinforcement of contaminated hernias, whether biologic or synthetic, remains an area of tremendous debate. It also represents an area in need of further investigation to clarify both the advantages and drawbacks of each material in a complex, contaminated or high-risk hernia repair. In this study population, the risk of hernia recurrence was similar across patients all CDC wound classes. This finding is somewhat counterintuitive, but patient selection was retrospective in this study, and definitive conclusions about comparative outcomes cannot be made. Nevertheless, just as major wound complications were increased with increasing CDC wound class, the authors would anticipate that recurrence rates would be increased among patients with higher wound classes.

The utilization of biologic materials in patients with risk factors for wound complications without active infection or contamination at the time of surgery remains an area of great debate. Known risk factors for postoperative skin and soft tissue infections following surgical procedures include diabetes, smoking, malnutrition, immunosuppression, obesity, staphylococcus aureus colonization in the nares, and remote body site infections [26, 27, 28]. Despite best practices, wound complications in high-risk populations remain problematic. There is little evidence to suggest that biologic grafts are superior to synthetic mesh in high-risk patients undergoing hernia repair [24]. As a result, operative decisions are often predicated upon local practice patterns and experience. As this study represents a prospective evaluation of previously operated patients, it is difficult to fully understand the rationale for the use of a biologic group for all patients. At the time of the study, biologic meshes were not uncommonly utilized in patients with CDC class 1 wounds with known risk factors for wound infection. Other authors have attempted to create classification schemes for patients felt to be at increased risk for wound complications in an attempt to justify the use of biologic materials [14]. The rationale for utilizing a biologic material in this group of patients is related to the potential for postoperative wound complications which may potentially result in mesh infections. In a study of 995 patients, incisional hernia patients with a prior history of wound infections were found to have a threefold increase in wound complications compared to patients without prior wound infections [29]. While not all wound infections will result in prosthetic infections, a small percentage of wound complications can be expected to result in mesh infections which are more likely to require further surgery.

Although biologic graft repairs are generally more expensive than synthetic mesh repairs [30], in the event of a postoperative infection, synthetic meshes are more likely to require mesh removal [23]. In 2003, the cost of a hospital-acquired infection (pulmonary, bloodstream, urinary, central nervous system, gastrointestinal, and soft tissue) in a medical patient was in excess of $15,000 [31]. Although peer-reviewed data describing the costs of a prosthetic mesh infection have not been reported in the literature, presumably the costs associated with mesh explantation would exceed the cost of treating hospital-acquired infections in medical patients. Accordingly, decisions for the utilization of a biologic graft material in patients with risk factors for wound complications must be individualized based on local factors and outcomes. In a study of 88 patients with Ventral Hernia Working Group Grade 2 hernias (CDC Grade 1 hernia with risk factors for wound infection) that underwent repair with synthetic mesh, the incidence of surgical site infection was 16 % of which only three patients required mesh excision [32]. Notwithstanding the cost of mesh infections, recurrent hernias add significant costs to the healthcare system and significantly increased recurrence rates are more likely to add to the cost of healthcare than rare mesh infections.

In the current study, the retrospective design makes it difficult to discern the rational for the decision to utilize a TS-HADM over a synthetic mesh. However, the recurrence rate in our study is substantially lower than the 61 % recurrence rate reported by Ko et al. [24] in the repair of non-contaminated hernias with a non-irradiated ADM. The improved outcomes may be related to patient factors, technique or alternatively the characteristics of the TS-HADM. Although the recurrence rate of 30 % in this patient group is not insignificant, it is not dissimilar to the recurrence rate reported with other ADMs in complex hernia repair [33]. In light of the economic health care climate, both the short-term and long-term costs associated with hernia care must be carefully considered. Future prospective trials comparing synthetic and biologic mesh materials in the high-risk non-contaminated hernia population are required to fully understand whether the additional cost of a biologic mesh compared to synthetic meshes is warranted.

In this study, the graft utilized to reinforce the hernia repair is processed with low-dose gamma irradiation to terminally sterilize the graft. In vitro studies have demonstrated an increase in the tensile strength of HADMs with low-dose gamma irradiation and significantly reduced elasticity without impacting proliferation of fibroblast cells [34]. Accordingly, the graft processing may impact its remodeling characteristics and potentially affect hernia repair outcomes. However, there are no human studies comparing gamma irradiated and non-gamma irradiated HADMs in hernia repair.

Abdominal wall reconstruction with a TS-HADM was associated with a significant hernia recurrence rate in patients at risk for developing postoperative wound complications. The best outcomes were seen when the TS-HADM was utilized as a reinforcement to the hernia repair at the time of a component separation procedure. Although wound complications occur frequently in this complex patient population, the need for graft removal is unlikely. Further prospective studies evaluating TS-HADMs in hernia repair are needed to define the optimal patient population for this tissue form.



This study was sponsored by CR Bard, Inc.

Conflict of interest

JR declares a conflict of interest directly related to the submitted work; he is a consultant for CR Bard, Inc. and is on their speaker bureau. JR also declares a conflict of interest not related to the submitted work; he is a board member of the Musculoskeletal Transplant Foundation, has grant funding from Ethicon EndoSurgery and Covidien, and is on an Ethicon speaker bureau. KH declares a conflict of interest not directly related to the submitted work; he is on an industry speaker bureau. CB, KF, and JK declare no conflicts of interest.


  1. 1.
    Burger JW, Luijendijk RW, Hop WC, Halm JA, Verdaasdonk EG, Jeekel J (2004) Long-term follow-up of a randomized controlled trial of suture versus mesh repair of incisional hernia. Ann Surg 240:578–583PubMedCentralPubMedGoogle Scholar
  2. 2.
    Mudge M, Hughes LE (1985) Incisional hernia: a 10 year prospective study of incidence and attitudes. Br J Surg 72(1):70–71CrossRefPubMedGoogle Scholar
  3. 3.
    Cengiz Y, Israelsson LA (1998) Incisional hernias in midline incisions: an eight year follow up. Hernia 2:175–177CrossRefGoogle Scholar
  4. 4.
    Hawn MT, Snyder CW, Graham LA, Gray SH, Finan KR, Vick CC (2010) Long-term follow-up of technical outcomes for incisional hernia repair. J Am Coll Surg 210(648–655):655–657Google Scholar
  5. 5.
    Flum DR, Horvath K, Koepsell T (2003) Have outcomes of incisional hernia repair improved with time? A population-based analysis. Ann Surg 237:129–135CrossRefPubMedCentralPubMedGoogle Scholar
  6. 6.
    Leber GE, Garb JL, Alexander AI, Reed WP (1998) Long-term complications associated with prosthetic repair of incisional hernias. Arch Surg 133:378–382CrossRefPubMedGoogle Scholar
  7. 7.
    Blatnik J, Jin J, Rosen M (2008) Abdominal hernia repair with bridging acellular dermal matrix–an expensive hernia sac. Am J Surg 196:47–50CrossRefPubMedGoogle Scholar
  8. 8.
    Diaz JJ Jr, Conquest AM, Ferzoco SJ, Vargo D, Miller P, Wu YC, Donahue R (2009) Multi-institutional experience using human acellular dermal matrix for ventral hernia repair in a compromised surgical field. Arch Surg 144:209–215CrossRefPubMedGoogle Scholar
  9. 9.
    Jin J, Rosen MJ, Blatnik J, McGee MF, Williams CP, Marks J, Ponsky J (2007) Use of acellular dermal matrix for complicated ventral hernia repair: does technique affect outcomes? J Am Coll Surg 205:654–660CrossRefPubMedGoogle Scholar
  10. 10.
    Brewer MB, Rada EM, Milburn ML, Goldberg NH, Singh DP, Cooper M, Silverman RP (2011) Human acellular dermal matrix for ventral hernia repair reduces morbidity in transplant patients. Hernia 15:141–145CrossRefPubMedGoogle Scholar
  11. 11.
    Milburn ML, Holton LH, Chung TL, Li EN, Bochicchio GV, Goldberg NH, Silverman RP (2008) Acellular dermal matrix compared with synthetic implant material for repair of ventral hernia in the setting of peri-operative Staphylococcus aureus implant contamination: a rabbit model. Surg Infect (Larchmt) 9:433–442CrossRefGoogle Scholar
  12. 12.
    Candage R, Jones K, Luchette FA, Sinacore JM, Vandevender D, Reed RL 2nd (2008) Use of human acellular dermal matrix for hernia repair: friend or foe? Surgery 144:703–709. (discussion 709–711)Google Scholar
  13. 13.
    Kim H, Bruen KB, Vargo D (2009) Acellular dermal matrix in the management of high-risk abdominal wall defects. Am J Surg 19:705–709Google Scholar
  14. 14.
    Ventral Hernia Working Group, Breuing K, Butler CE, Ferzoco S, Franz M, Hultman CS, Kilbridge JF, Rosen M, Silverman RP, Vargo D (2010) Incisional ventral hernias: review of the literature and recommendations regarding the grading and technique of repair. Surgery 148:544–558Google Scholar
  15. 15.
    Espinosa-de-Los-Monteros A, de la Torre JI, Marrero I, Andrades P, Davis MR, Vásconez LO (2007) Utilization of human cadaveric acellular dermis for abdominal hernia reconstruction. Ann Plast Surg 58(3):264–267CrossRefPubMedGoogle Scholar
  16. 16.
    Ko JH, Wang EC, Salvay DM, Paul BC, Dumanian GA (2009) Abdominal wall reconstruction: lessons learned from 200 “components separation” procedures. Arch Surg 144:1047–1055CrossRefPubMedGoogle Scholar
  17. 17.
    Roth JS, Dexter DD, Lumpkins K, Bochicchio GV (2009) Hydrated vs. freeze-dried human acellular dermal matrix for hernia repair: a comparison in a rabbit model. Hernia 13:201–207CrossRefPubMedGoogle Scholar
  18. 18.
    Badylak S (2007) The extracellular matrix as a biologic scaffold material. Biomaterials 28:3587–3593CrossRefPubMedGoogle Scholar
  19. 19.
    Orenstein S, Qiao Y, Kaur M, Klueh U, Kreutzer D, Novitsky Y (2010) In vitro activation of human peripheral blood mononuclear cells induced by human biologic meshes. J Surg Res 158:10–14CrossRefPubMedGoogle Scholar
  20. 20.
    Diaz DF, Roth JS (2011) Laparoscopic paraesophageal hernia repair with acellular dermal matrix cruroplasty. JSLS 15:355–360CrossRefPubMedCentralPubMedGoogle Scholar
  21. 21.
    Carlson MA, Frantzides CT, Shostrom VK, Laguna LE (2008) Minimally invasive ventral herniorrhaphy: an analysis of 6,266 published cases. Hernia 12:9–22CrossRefPubMedGoogle Scholar
  22. 22.
    Ramirez OM, Ruas E, Dellon AL (1990) “Components separation” method for closure of abdominal-wall defects: an anatomic and clinical study. Plast Reconstr Surg 86:519–526CrossRefPubMedGoogle Scholar
  23. 23.
    Sailes FC, Walls J, Guelig D, Mirzabeigi M, Long WD, Crawford A, Moore JH Jr, Copit SE, Tuma GA, Fox J (2010) Synthetic and biological mesh in component separation: a 10-year single institution review. Ann Plast Surg 64:696–698PubMedGoogle Scholar
  24. 24.
    Ko JH, Salvay DM, Paul BC, Wang EC, Dumanian GA (2009) Soft polypropylene mesh, but not cadaveric dermis, significantly improves outcomes in midline hernia repairs using the components separation technique. Plast Reconstr Surg 124:836–847CrossRefPubMedGoogle Scholar
  25. 25.
    Farrow B, Awad S, Berger DH, Albo D, Lee L, Subramanian A, Bellows CF (2008) More than 150 consecutive open umbilical hernia repairs in a major Veterans Administration Medical Center. Am J Surg 196:647–651CrossRefPubMedGoogle Scholar
  26. 26.
    Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR, The Hospital Infection Control Practices Advisory Committee (1999) Guideline for prevention of surgical site infection, 1999. Infect Control Hosp Epidemiol 20:247–278Google Scholar
  27. 27.
    Owens CD, Stoessel K (2008) Surgical site infections: epidemiology, microbiology, and prevention. J Hosp Infect 70(Suppl 2):3–10CrossRefPubMedGoogle Scholar
  28. 28.
    Kanters AE, Krpata DM, Blatnik JA, Novitsky YM, Rosen MJ (2012) Modified hernia grading scale to stratify surgical site occurrence after open ventral hernia repairs. J Am Coll Surg 215:787–793CrossRefPubMedGoogle Scholar
  29. 29.
    Houck JP, Rypins EB, Sarfeh IJ, Juler GL, Shimoda KJ (1989) Repair of incisional hernia. Surg Gynecol Obstet 169:397–399PubMedGoogle Scholar
  30. 30.
    Reynolds D, Davenport DL, Korosec RL, Roth JS (2013) Financial implications of ventral hernia repair: a hospital cost analysis. J Gastrointest Surg 17(1):159–166CrossRefPubMedGoogle Scholar
  31. 31.
    Roberts RR, Scott RD 2nd, Cordell R, Solomon SL, Steele L, Kampe LM, Trick WE, Weinstein RA (2003) The use of economic modeling to determine the hospital costs associated with nosocomial infections. Clin Infect Dis 36:1424–1432CrossRefPubMedGoogle Scholar
  32. 32.
    Krpata DM, Blatnik JA, Novitsky YW, Rosen MJ (2013) Evaluation of high-risk, comorbid patients undergoing open ventral hernia repair with synthetic mesh. Surgery 153:120–125CrossRefPubMedGoogle Scholar
  33. 33.
    Bochicchio GV, De Castro GP, Bochicchio KM, Weeks J, Rodriguez E, Scalea TM (2013) Comparison study of acellular dermal matrices in complicated hernia surgery. J Am Coll Surg 217(4):606–613CrossRefPubMedGoogle Scholar
  34. 34.
    Gouk SS, Lim T-M, Teoh S-H, Sun WQ (2008) Alterations of human acellular tissue matrix by gamma irradiation: histology, biomechanical property, stability, in vitro cell repopulation, and remodeling. J Biomed Mat Res Part B Appl Biomat 84:205–217CrossRefGoogle Scholar

Copyright information

© The Author(s) 2014

Open AccessThis article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.

Authors and Affiliations

  • J. S. Roth
    • 1
  • C. Brathwaite
    • 2
  • K. Hacker
    • 3
  • K. Fisher
    • 4
  • J. King
    • 4
  1. 1.Department of SurgeryUniversity of Kentucky College of MedicineLexingtonUSA
  2. 2.Winthrop University HospitalMineolaUSA
  3. 3.Benrus Surgical Associates Inc.St. PetersUSA
  4. 4.St. Francis Hospital, Inc.TulsaUSA

Personalised recommendations